ES2187440T3 - Utilizacion de orosomucoide en un preparado farmaceutico para el tratamiento de pancreatitis aguda. - Google Patents

Utilizacion de orosomucoide en un preparado farmaceutico para el tratamiento de pancreatitis aguda.

Info

Publication number
ES2187440T3
ES2187440T3 ES00903429T ES00903429T ES2187440T3 ES 2187440 T3 ES2187440 T3 ES 2187440T3 ES 00903429 T ES00903429 T ES 00903429T ES 00903429 T ES00903429 T ES 00903429T ES 2187440 T3 ES2187440 T3 ES 2187440T3
Authority
ES
Spain
Prior art keywords
orosomucoid
treatment
pharmaceutical preparation
acute pancreatitis
pancreatitis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00903429T
Other languages
English (en)
Inventor
Wilfried Auer
Eva-Maria Muchitsch
Ludwig Pichler
Hans-Peter Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Baxter AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter AG filed Critical Baxter AG
Application granted granted Critical
Publication of ES2187440T3 publication Critical patent/ES2187440T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Utilización de orosomucoide para la elaboración de un preparado farmacéutico para el tratamiento de pancreatitis aguda.
ES00903429T 1999-02-18 2000-02-15 Utilizacion de orosomucoide en un preparado farmaceutico para el tratamiento de pancreatitis aguda. Expired - Lifetime ES2187440T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0027199A AT408946B (de) 1999-02-18 1999-02-18 Verwendung von orosomucoid zur herstellung einer pharmazeutischen präparation

Publications (1)

Publication Number Publication Date
ES2187440T3 true ES2187440T3 (es) 2003-06-16

Family

ID=3486111

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00903429T Expired - Lifetime ES2187440T3 (es) 1999-02-18 2000-02-15 Utilizacion de orosomucoide en un preparado farmaceutico para el tratamiento de pancreatitis aguda.

Country Status (10)

Country Link
EP (1) EP1150702B1 (es)
JP (1) JP2002538087A (es)
AT (2) AT408946B (es)
AU (1) AU2525700A (es)
CA (1) CA2362664A1 (es)
DE (1) DE50000676D1 (es)
DK (1) DK1150702T3 (es)
ES (1) ES2187440T3 (es)
PT (1) PT1150702E (es)
WO (1) WO2000048624A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9904289D0 (sv) 1999-11-26 1999-11-26 Niklas Arnberg Method and camposition for the treatment of adenovairal ocular infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6118723A (ja) * 1984-07-05 1986-01-27 Chemo Sero Therapeut Res Inst 肝疾患治療剤
JPH09502728A (ja) * 1993-09-15 1997-03-18 アルファ セラピューティク コーポレイション α▲下１▼−酸性糖タンパク質の精製方法及び精製物
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
AT405241B (de) * 1997-03-10 1999-06-25 Immuno Ag Verwendung von humanem alpha1-sauren glycoprotein zur herstellung einer pharmazeutischen präparation

Also Published As

Publication number Publication date
ATE226443T1 (de) 2002-11-15
EP1150702A2 (de) 2001-11-07
EP1150702B1 (de) 2002-10-23
JP2002538087A (ja) 2002-11-12
AU2525700A (en) 2000-09-04
DK1150702T3 (da) 2003-02-24
CA2362664A1 (en) 2000-08-24
PT1150702E (pt) 2003-03-31
AT408946B (de) 2002-04-25
DE50000676D1 (de) 2002-11-28
WO2000048624A3 (de) 2000-12-14
ATA27199A (de) 2001-09-15
WO2000048624A2 (de) 2000-08-24

Similar Documents

Publication Publication Date Title
PT1143967E (pt) Utilizacao de derivados anticonvulsivos para o tratamento de cefaleias em salvas
DE60106954D1 (de) Resorcin-derivate
RS50091B (sr) Upotreba retigabina u lečenju neuropatskog bola
ZA200107450B (en) Dimeric compounds and their use as inhibitors of neuraminidase.
AR033555A1 (es) Producto para el tratamiento del carcinoma de receptor de estrogeno positivo, y uso de dicho producto para preparar medicamentos
UY27720A1 (es) Aroilpiridinonas monocíclicas,
ATE320436T1 (de) Dimere pyrrolobenzodiazepine
BR0309544A (pt) Preparação farmacêutica contendo oxicodona e naloxona
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
IL196301A0 (en) Medicament for the treatment of hapatitis c
NO20030627D0 (no) Hydrogel-drevet medikament doseringsform
DE60029798D1 (de) Ring zur verformung des magens
GB0002336D0 (en) Medicaments
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
PT1030667E (pt) Utilizacao de mirtazapina para o fabrico de um medicamento para o tratamento de apenas do sono
PL1713438T3 (pl) Mydło lecznicze
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
PT1152756E (pt) Derivados de anticonvulsivo uteis no tratamento do autismo
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
ES2187440T3 (es) Utilizacion de orosomucoide en un preparado farmaceutico para el tratamiento de pancreatitis aguda.
PT1212119E (pt) Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
AR030660A1 (es) Composicion farmaceutica para la prevencion o el tratamiento de una enfermedad asociada con un exceso de la produccion de il-12